Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study

Dysregulation of MiR-21, MiR-221 and MiR-451 During Neoadjuvant Treatment of Breast Cancer: A Prospective Study

Background: Breast cancer is highly heterogeneous disease in which different responses are observed to the same treatment for different subtypes and extents of similar diseases. Considering this scenario, the search for tumor biomarkers is indispensable, with current evidence suggesting that circula...

Full description

Saved in:
Bibliographic Details
Main Authors: Carine Bispo Patury, Brenda Luanny Maia Santos, Anna Lucia Carvalho Matos, José Slabi, Luciene Cristina Campos Gastalho, Carla Martins Kaneto
Format: Article
Language:English
Published: MDPI AG 2024-12-01
Series:Biomolecules
Subjects:
breast cancer
neoadjuvant treatment
molecular biomarker
microRNA
Online Access:https://www.mdpi.com/2218-273X/14/12/1580
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.mdpi.com/2218-273X/14/12/1580

Similar Items